Delivering biochemicals with precision using bioelectronic devices enhanced with feedback control

PLoS One. 2024 May 14;19(5):e0298286. doi: 10.1371/journal.pone.0298286. eCollection 2024.

Abstract

Precision medicine endeavors to personalize treatments, considering individual variations in patient responses based on factors like genetic mutations, age, and diet. Integrating this approach dynamically, bioelectronics equipped with real-time sensing and intelligent actuation present a promising avenue. Devices such as ion pumps hold potential for precise therapeutic drug delivery, a pivotal aspect of effective precision medicine. However, implementing bioelectronic devices in precision medicine encounters formidable challenges. Variability in device performance due to fabrication inconsistencies and operational limitations, including voltage saturation, presents significant hurdles. To address this, closed-loop control with adaptive capabilities and explicit handling of saturation becomes imperative. Our research introduces an enhanced sliding mode controller capable of managing saturation, adept at satisfactory control actions amidst model uncertainties. To evaluate the controller's effectiveness, we conducted in silico experiments using an extended mathematical model of the proton pump. Subsequently, we compared the performance of our developed controller with classical Proportional Integral Derivative (PID) and machine learning (ML)-based controllers. Furthermore, in vitro experiments assessed the controller's efficacy using various reference signals for controlled Fluoxetine delivery. These experiments showcased consistent performance across diverse input signals, maintaining the current value near the reference with a relative error of less than 7% in all trials. Our findings underscore the potential of the developed controller to address challenges in bioelectronic device implementation, offering reliable precision in drug delivery strategies within the realm of precision medicine.

MeSH terms

  • Computer Simulation
  • Drug Delivery Systems / instrumentation
  • Feedback
  • Humans
  • Machine Learning
  • Precision Medicine* / methods

Grants and funding

This research is sponsored by the DARPA Biotechnologies Office (DARPA/BTO, https://www.darpa.mil/) and was accomplished under Cooperative Agreement Number DC20AC00003. Funding was secured by M.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.